HealthCare Chaplaincy - Michael H. Schoen

Michael H. Schoen is the Chief of Staff to the CEO of BeiGene USA Inc, a globally-focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. Prior to this he was Managing Director & Head of Latin America & Caribbean Debt Capital Markets for Scotiabank. Michael also worked at Credit Suisse, DLJ, and J.P. Morgan in their respective Emerging Markets groups. Michael graduated from the Massachusetts Institute of Technology with a B.S. in Management from the Sloan School of Management. He remains involved with MIT, serving on the Visiting Committee for the Department of Athletics, Physical Education, and Recreation. Michael is also serves on the Foundation Board of The Ohio State University's Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.